Log in to search using one of your social media accounts:

How Do I Keep My Prescription Stimulant Safe At College?

Discussion Going away to college presents new and exciting opportunities for young adults. It also is an important time for transitioning many adult responsibilities to the young adult too. Keeping safe is important and safety tips for college can be reviewed here. Any medication can be abused. Prescription stimulants are no different. Normally prescription stimulants are used for treatment of attention deficit disorder, narcolepsy and treatment resistant depression. They can help increase alertness, attention, and energy, cognition, learning and memory. However for these reasons and because they are easy to obtain and relatively inexpensive, prescription stimulants are commonly abused on college campuses. Side effects of prescription stimulant abuse includes addiction, cardiovascular side effects, withdrawal symptoms (fatigue, sleep problems or depression) and even hostility, paranoia or psychosis. Learning Point While some of the recommendations for safe use of prescription medications in college are specific for controlled substances like stimulants, they are generally true for any medication. Students and their families should consider the following questions: Who will prescribe the medication? Regular hometown physician, student health center, local physician in the college location, or a combination. How often will the student need to followup with the prescriber? The regular physician is often very willing to continue to prescribe medications with followup arranged...
Source: PediatricEducation.org - Category: Pediatrics Authors: Tags: Uncategorized Source Type: news

Related Links:

ConclusionMuslim children with a mean age of nine years reported longer screen exposure, earlier bedtimes and longer sleep duration, but more sleep disturbances, than Jewish children. Cultural sleep practices may contribute to the differences in sleep patterns and sleep disturbances of Jewish and Muslim children in Israel.This article is protected by copyright. All rights reserved.
Source: Acta Paediatrica - Category: Pediatrics Authors: Tags: Regular Article Source Type: research
In this study we aimed to identify the thresholds for interdisciplinary collaboration amongst practitioners when treating severely depressed patients. In addition, we aimed to identify specific and feasible steps that may add to improved collaboration amongst first and second level Belgian health care providers when treating depressed patients. In two standard focus groups (n = 8; n = 12), general practitioners and psychiatrists first outlined current practice and its shortcomings. In a next phase, the same participants were gathered in nominal groups to identify and prioritise steps that could give rise to improved collab...
Source: International Journal of Integrated Care - Category: Nursing Source Type: research
Days after Neos Therapeutics (NSDQ:NEOS) nabbed U.S. regulatory approval for its controlled-release formulation of methylphenidate, Shire (NSDQ:SHPG) said it won a nod from the FDA for its long-acting ADHD drug. The drug, Mydayis, is made up of the same active ingredient in Shire’s ADHD treatment Adderall XR – amphetamine – but it is designed to last up to 16 hours. Adderall XR is formulated to control symptoms in patients for up to 12 hours. Get the full story at our sister site, Drug Delivery Business News. The post Another extended-release ADHD drug wins FDA nod appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Food & Drug Administration (FDA) Neurological Pharmaceuticals Regulatory/Compliance Wall Street Beat neostherapeutics Shire Plc. Source Type: news
ConclusionsResults from UMBRELLA show that this novel study design is feasible and acceptable to patients in a clinical breast cancer setting. We invite researchers who are interested in conducting randomized or observational studies within the UMBRELLA cohort to contact the UMBRELLA scientific advisory board.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
Employers who suspect someone of using drugs on the job may be reluctant to intervene because they fear they’ll be charged with discrimination. On Jason’s first day of work at an old-fashioned Wall Street law firm, he was so high on cocaine and heroin that his mother warned him, “You can’t go in there. You don’t look well.” But as Jason, now nearly ten years sober and with the easy confidence of a successful lawyer, explains, “I was determined to show up, though I should have never been anywhere near an office, let alone the orientation for summer associates. But the way it works, ...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Addiction Alcoholism Disorders Industrial and Workplace Publishers Recovery Substance Abuse The Fix employees employers Kristen McGuiness liability Source Type: blogs
A campaign to generate awareness around postpartum depression is facing criticism for its imagery. Sage Therapeutics launched “Silence Sucks” last month to encourage women to speak out about their struggles with PPD and seek treatment. The biopharmaceutical company is developing new treatment options for the disorder. While many have praised Sage Therapeutics’ efforts to help women with PPD and shatter the stigma around this topic, the “Silence Sucks” campaign has come under fire for its choice of visuals. A post shared by Sage Therapeutics (@sagebiotech) on May 7, 2017 at 4:55pm PDT Ads...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
Between school and social demands, lots of children feel stress, but at what point does anxiety cross the line and become a mental health concern? Thriving sat down with Keneisha Sinclair-McBride, PhD, a clinical psychologist in the Department of Psychiatry at Boston Children’s, to better understand what separates serious forms of anxiety from normal worrying, whether seeing a therapist is warranted and how to handle anxiety at home. My child is a “worrier.” What degree of anxiety is normal and what should cause me concern? Occasional worries, like worries about the start of the school year or fitting in...
Source: Thrive, Children's Hospital Boston - Category: Pediatrics Authors: Tags: Ask the Expert Mental Health Parenting anxiety Department of Psychiatry Keneisha Sinclair-McBride worrying Source Type: news
Henry “Hank” Deutschendorf, one of two twins who played baby Oscar in 1989′s “Ghostbusters II,” has died. He was 28. Henry’s brother William Deutschendorf announced the tragic news via a website dedicated to raising funds to fight schizoaffective disorder, which Henry suffered from.  Henry reportedly took his own life at his home in Escondido, California, last Wednesday, according to TMZ. In 2008, he was diagnosed with schizoaffective disorder, a chronic mental health condition characterized by a combination of bipolar disorder, schizophrenia and depression.  “H...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
While most patients with panic disorder respond to selective serotonin reuptake inhibitors, benzodiazepines, and/or a combination of the two, the risk of relapse after drug discontinuation is known to be high. Astudy in theJournal of Clinical Psychopharmacology now suggests that patients who take clonazepam may be at a lower risk of relapse than those treated with paroxetine.The findings were based on an observational, prospective, six-year follow-up study of patients with panic disorder who participated in anopen, randomized trial in which they were assigned to take either clonazepam (0.5 mg/d to 2 mg/d) or paro...
Source: Psychiatr News - Category: Psychiatry Tags: anxiety disorders benzodiazepines clonazepam Journal of Clinical Psychopharmacology panic disorder paroxetine Rafael C. Freire SSRIs taper treatment discontinuation Source Type: research
Patients with low back pain who are depressed are more likely to be prescribed opioids, and to be prescribed higher doses, a new study finds.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: Addiction | Advertising | Anxiety | Cardiology | Cardiovascular | Child Abuse | Children | Concerta | Databases & Libraries | Depression | Drugs & Pharmacology | Health Management | Heart | Hospitals | Hyperactivity | Internet | Learning | Legislation | Men | Methylphenidate | Narcolepsy | Pediatrics | Ritalin | Sleep Disorders | Sleep Medicine | Students | Substance Abuse | Toxicology | Universities & Medical Training | Vitamins | Weight Loss